About company
Kleo is developing two types of small molecules to treat cancer, infectious diseases, and a broad range of indications: Antibody Recruiting Molecules (ARMs) and Synthetic Antibody Mimics (SyAMs). We believe our technology represents a breakthrough in safer, more efficacious, and more convenient treatment options.
- US
- deb@celebrationradio.com
- 209-723-1015
- www.celebrationradio.com/#
- Not verified company
